Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease

• Status: Completed
• Trial end date: 2013-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether a brief course of SSKI (saturated solution of potassium iodide) administered preoperatively provides any benefit in the surgical management of patients undergoing thyroidectomy as definitive management of their Graves Disease.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Massachusetts, Worcester
• Treatments: Iodine

Criteria

Inclusion Criteria:

• Adult patients with a clinical diagnosis of Graves Disease

• Patients who have selected surgical resection as treatment of their Graves Disease

• Prior use of anti thyroid medication so that patient is clinically and biochemically euthyroid

Exclusion Criteria:

• Patients deemed unfit for surgery by operating surgeon or anesthesist

• Patients who are clinically hyperthyroid or have T3 or T4 levels 2X the upper limit of normal